Your session is about to expire
← Back to Search
Corneal Collagen Cross-Linking for Keratoconus
Study Summary
This trial found that the PXL-Platinum 330 system is safe and effective for corneal collagen cross-linking in eyes with corneal thinning conditions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You are allergic or have a known sensitivity to the study medications.I do not have conditions like nystagmus that affect my ability to keep my gaze steady.I am 8 years old or older.My eye condition is related to keratoconus, surgery complications, or pellucid marginal degeneration.I have had eye conditions that could complicate treatment, excluding vision correction issues.My eye condition shows signs like Fleischer ring or Munson's sign.I can stop wearing my contact lenses before the eye test as required.You have a medical condition that may slow down or disrupt the healing process of your skin or other tissues.
- Group 1: Pulsed 5mW/cm2
- Group 2: Pulsed 8mW/cm2
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the FDA recognize PXL-330 Platinum device and Peschke riboflavin solution as a viable combination for crosslinking treatments?
"PXL-330 Platinum device combined with Peschke riboflavin solution has limited data confirming efficacy and safety, so it earned a score of 1."
Is this research venture recruiting participants at present?
"Per the details found on clinicaltrials.gov, this medical experiment is still searching for participants. The trial was initially posted to the database on February 1st 2021 and has been amended as recently as September 14th 2022."
What is the present size of the cohort in this trial?
"Affirmative. Evidence on clinicaltrials.gov reveals that this research endeavor, which was first uploaded to the platform on February 1st 2021, is actively looking for participants. Approximately 1000 individuals need to be recruited from one location."
To what maladies is the PXL-330 Platinum device in conjunction with Peschke riboflavin solution typically applied?
"The PXL-330 Platinum device, when paired with Peschke riboflavin solution, is typically used in dietary and nutritional therapies. However, it may be employed to relieve joint pain or supplement vitamin intake for those suffering from deficiencies."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger